SCHEMBL8260712

SCHEMBL8260712

COc1ccc(Cl)cc1N1CCN(Cc2c(Cl)c(=O)n(C3=CC=C(OC(F)(F)F)CC3)n2C)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 13/20 0.41
ADRA1A P35348 13/20 0.41
ADRA1B P35368 13/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
HTR1A P08908 3/20 0.39
HTR1B P28222 1/20 0.38
CYP2C9 P11712 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
LMNA P02545 1/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8259582 0.90 ALDH1A1 (0.41) ADRA1DADRA1AADRA1BMAPTHTR1A
SCHEMBL4334313 0.83 ADRA1D (0.43) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL4324270 0.80 ADRA1D (0.49) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL4328117 0.80 ADRA1D (0.45) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL4318684 0.79 MAPT (0.51) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL4331760 0.78 ADRA1D (0.55) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL8260355 0.78 ADRA1D (0.46) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL4319280 0.74 ADRA1D (0.49) ADRA1DADRA1AADRA1BKDM4EMAPT
SCHEMBL4331305 0.73 ALDH1A1 (0.43) ADRA1DADRA1AADRA1BMAPTHTR1A
SCHEMBL4321301 0.73 MAPK1 (0.47) ADRA1DADRA1AADRA1BKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed